Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInsig Ai Plc Regulatory News (INSG)

Share Price Information for Insig Ai Plc (INSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.00
Bid: 17.50
Ask: 18.50
Change: -0.50 (-2.70%)
Spread: 1.00 (5.714%)
Open: 18.50
High: 18.50
Low: 18.00
Prev. Close: 18.50
INSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate changes

13 Aug 2021 07:30

RNS Number : 5760I
Insig AI Plc
13 August 2021
 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. It forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

13 August 2021

Insig AI plc

("Insig AI", the "Company" or the "Group")

 

Directorate Changes

 

Insig AI plc today announces the resignation of Matthew Farnum-Schneider, Executive Chairman. He will be leaving the Company after a short handover period. The Board is pleased to advise that Mr. Richard Bernstein a long-term supporter and shareholder of the Company, has agreed to become interim Non-Executive Chairman until such time as a replacement can be appointed. The Company has commenced a search for a permanent independent non-executive to chair the Group.

Mr. Farnum-Schneider joined the Group in August 2019 and has overseen its transformation from a sports coaching business through to the completion of the acquisition and reverse takeover of Insight Capital Partners Limited, while also supporting the delivery of Insig's suite of data science and machine learning products which will help drive the Group's revenue.

Having successfully achieved these milestones, Mr. Farnum-Schneider has decided to focus on other value-creating opportunities. Until a replacement can be appointed, Richard Bernstein will be the interim Non-Executive Chairman of Insig AI, with immediate effect.

Richard Bernstein qualified as a chartered accountant in 1989 and between 1994 and 1996 ran his own specialist research house, Amber Analysis. Amber Analysis provided a risk management service for UK institutions managing over £100 billion in assets. Mr Bernstein subsequently joined Schroder Securities as an equities analyst and became the Chief Executive Officer of AIM-listed Eurovestech plc, a high technology development capital fund. In 2008, Mr Bernstein was appointed as an investment manager of Crystal Amber Fund Limited, an AIM-listed activist fund investing predominately in small to mid-cap UK equities.

Richard Bernstein said: "I am delighted to become Chairman of Insig AI on an interim basis to help guide the Company through its next phase of development. I believe the Company has very exciting prospects in the fast-growing field of applying AI and machine learning more intensively and productively in the financial services industry. Having been involved in the Company from the beginning, and helping to bring Insig AI to AIM, it is a pleasure to chair its Board, while we search for a long-term replacement."

Steve Cracknell, Insig AI plc CEO commented: "I want to thank Matt for his work over the past couple years to shepherd the marriage between Catena and Insight Capital through where we are today and wish him all the best in his future endeavours."

Matthew Farnum-Schneider commented: "Having completed a successful IPO, and with the Insig AI executive team led by Steve bedded in, I feel it is now time for me to move on to a fresh challenge. I look forward to watching Insig AI grow and develop in the future."

In accordance with Schedule 2(g) of the AIM Rules, Richard Philip Bernstein (aged 58) holds or has held in the past five years the following directorships and partnerships:

Current

Last 5 years

Better Lives For Pets

Barbican Trust Centre Limited (The)

Crystal Amber Advisers (UK) LLP

Toluna Holdings Limited

Crystal Amber Asset Management (Guernsey) Limited

Toluna UK Limited

Share & Share Alike Limited

Audionamix Limited

Eurovestech plc

Thin Film Electronics ASA

Audionamix SA

 

 

 

Richard Bernstein holds 12,435,000 ordinary shares of 1 pence each in the Company, equivalent to 12.6% of the Company's issued share capital.

Also, in accordance with the disclosure requirements of Schedule 2(g), Richard Bernstein has twice previously been appointed as a director where the company had already entered into a company voluntary arrangement ("CVA") or compulsory liquidation as nominated by a shareholder of the respective companies:

Richard Bernstein was appointed to the board of directors of JJB Sports plc on 6 May 2011. On 22 March 2011, prior to Mr Bernstein's appointment, JJB Sports plc entered into a CVA which concluded on 1 October 2012. On 1 October 2012 JJB Sports plc, was placed into administration with a total deficiency of £266,898,383 of which after the administration a deficiency of £460,900 endured. Richard Bernstein was appointed to the board of directors of Easybusiness SA on 19 January 2005. On 27 November 2002, prior to Mr Bernstein's appointment, the Commercial Court of Nanterre, France (the "Court"), ordered a judicial liquidation of Easybusiness SA. On 31 March 2009 Easybusiness SA was struck off the registry for companies following the conclusion of insufficient assets by the Court.

 

This announcement has been approved by Steve Cracknell, CEO, on behalf of the Company.

For further information, please visit www.insg.ai, or contact:

 

Insig AI plc

 

Steve Cracknell, CEO

 

Via SEC Newgate

Zeus Capital Limited (Nominated Adviser & Broker)

 

David Foreman / James Hornigold

 

 

+44 (0) 203 829 5000

SEC Newgate (Financial PR)

Robin Tozer / Tom Carnegie / Richard Bicknell 

 

+44 (0) 7540 106 366

insigai@secnewgate.co.uk

 

 

 

    

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUOUNRAVUWARR
Date   Source Headline
17th Oct 20227:00 amRNSPartnership agreement with BRAIN
12th Oct 20227:00 amRNSConvertible Loan Facility Agreement and drawdown
30th Sep 202212:13 pmRNSResult of Annual General Meeting & General Meeting
30th Sep 20227:00 amRNSContract win
26th Sep 20227:00 amRNSConvertible Loan Facility drawdown
20th Sep 20227:00 amRNSChange of Registered Office
12th Sep 20227:00 amRNSConvertible Loan Facility Agreement
9th Sep 20227:00 amRNSFinal Results, Posting of Report and Notice of GM
8th Sep 20227:00 amRNSNotice of AGM
30th Aug 20227:00 amRNSConvertible Loan Facility Agreement and Drawdown
2nd Aug 20227:00 amRNSDirector/PDMR Shareholding
29th Jul 20227:00 amRNSDirector/PDMR Shareholding
26th Jul 20227:00 amRNSConvertible Loan Facility Agreement drawdown
19th Jul 20227:00 amRNSDirectors' Disclosure
6th Jul 20227:00 amRNSDirector/PDMR Shareholding
1st Jul 20227:00 amRNSDirector/PDMR Shareholding
17th Jun 202210:30 amRNSConvertible loan agreement and drawdown
31st May 20227:00 amRNSData partnership and research agreement
5th May 20227:00 amRNSData share partnership agreement with Snowflake
4th May 20227:00 amRNSConvertible Loan Facility Agreement and drawdown
28th Apr 20227:00 amRNSUpdate on agreement with CarVal Investors, L.P
26th Apr 20227:00 amRNSDirector/PDMR Shareholding
25th Apr 20227:00 amRNSContract win, trading update and Board changes
11th Apr 20227:00 amRNSDirectorate Change
24th Mar 20227:00 amRNSDirector/PDMR Shareholding
22nd Mar 20227:00 amRNSDirector/PDMR Shareholding
21st Mar 20227:00 amRNSTrading and operations update
25th Feb 20227:00 amRNSFurther agreement with CarVal Investors, L.P.
7th Feb 20227:00 amRNSInsig AI selected for PwC Scale FinTech programme
14th Jan 20227:00 amRNSDirector/PDMR Shareholding
6th Jan 20221:41 pmRNSDirector/PDMR Shareholding
30th Dec 20217:00 amRNSDirectorate change
23rd Dec 202112:55 pmRNSDirector/PDMR Shareholding
23rd Dec 20218:42 amRNSDirector/PDMR Shareholding
22nd Dec 20217:00 amRNSInterim Results
13th Dec 20217:00 amRNSContract win
10th Dec 20217:00 amRNSColm McVeigh appointment to the Board
19th Nov 202111:36 amRNSDirector/PDMR Shareholding
19th Nov 20217:00 amRNSDirector/PDMR Shareholding
18th Nov 20217:00 amRNSAcquisition of FDB Systems Limited
15th Nov 20217:00 amRNSProof of concept signed with asset manager
10th Nov 20217:00 amRNSESG scoring solution delivered to CarVal Investors
10th Nov 20217:00 amRNSColm McVeigh appointed as Chief Commercial Officer
4th Nov 20217:00 amRNSInvestor Presentation
1st Nov 20217:00 amRNSInsig AI Becomes a Sponsor of the UK's APPG on ESG
4th Oct 20217:00 amRNSRelease of Insig Portfolio 2.0
30th Sep 202111:10 amRNSResult of AGM
15th Sep 20217:00 amRNSLaunch of Insig ESG
17th Aug 20217:00 amRNSCarVal HY and IG product lines partnership
13th Aug 20217:30 amRNSDirectorate changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.